• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Impulse Dynamics

The largest medtech funding rounds of 2024

December 23, 2024 By Sean Whooley

Over the past 12 months, a number of medtech companies at various stages hauled in significant funding rounds to support their innovations. Technologies that were supported by hundreds of millions of dollars in 2024 included pulsed-field ablation, brain-computer interfaces (BCIs), AI-enabled surgical software and more. In all, the amount of medtech companies receiving more than […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Wall Street Beat Tagged With: Amber Therapeutics, Blackrock Neurotech, Capstan Medical, caresyntax, histosonics, Imperative Care, Impulse Dynamics, INSIGHTEC, Kardium, Kestra Medical, Magenta Medical, Mainstay Medical, Oura, Precision Neuroscience

Impulse Dynamics expands leadership team

September 25, 2024 By Danielle Kirsh

Impulse Dynamics this week announced four new appointments to its executive team. The company appointed Noel Colón as chief operating officer, Peter Donato as chief financial officer, Paul Bae as chief administrative officer and Anthony Hong as chief science and strategy officer. “We are pleased to add these proven leaders to the Impulse Dynamics executive […]

Filed Under: Business/Financial News, Cardiovascular Tagged With: Impulse Dynamics, Personnel Moves

Impulse Dynamics raises $136M for heart failure therapy

February 14, 2024 By Sean Whooley

Impulse Dynamics announced today that it raised $136 million in financing to accelerate its investment in its heart failure therapy. Perceptive Advisors, Redmile Group, Alger and Hobart Healthcare led the financing round. The company expects it to accelerate investment in global commercialization, technology, product innovation and clinical evidence development. Marlton, New Jersey–based Impulse Dynamics plans […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Featured, Funding Roundup, Structural Heart Tagged With: Impulse Dynamics

CMS agrees to cover ‘breakthrough’ medical devices

August 31, 2020 By Nancy Crotti

Medicare patients will have coverage for medical devices the FDA designates as breakthrough technology under a proposed rule released this morning. Once the Medicare Coverage of Innovative Technology (MCIT) final rule goes into effect, national Medicare coverage will begin on the date a breakthrough device’s FDA market authorization would begin and continue for 4 years. […]

Filed Under: Featured, Food & Drug Administration (FDA), Medicare, Regulatory/Compliance Tagged With: AdvaMed, breakthrough device, Centers for Medicare and Medicaid Services (CMS), Edwards Lifesciences, FDA, Impulse Dynamics, Medtronic, U.S. Department of Health and Human Services

The 18 most innovative medical devices of 2020

July 24, 2020 By Danielle Kirsh

The Galien Foundation recently announced nominees for most innovative medical devices for its 14th Annual Prix Galien USA Awards. The foundation bestows the Prix Galien Award annually to examples of outstanding biomedical and technology products that are designed to improve the human condition. “As we celebrate 50 years of the Prix Galien process, we are honored […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Endoscopic, Featured, Implants, Oncology, Pain Management, Patient Monitoring, Respiratory, Structural Heart, Vascular, Vision Tagged With: Abbott, BD, Biotronik, Boston Scientific, Edwards Lifesciences, endomag, Glaukos, Impulse Dynamics, Medtronic, Pear Therapeutics, Prix Galien USA, Pulmonx, Sonendo, Teva Pharmaceuticals

Impulse Dynamics appoints medical director

March 11, 2020 By Sean Whooley

Cardiac contractility modulation (CCM) therapy developer Impulse Dynamics announced that it is appointing Dr. Ishu Rao as its medical director. Rao previously spent 17 years in a clinical practice treating heart failure patients, with a focus on interventional therapies, according to a news release. He received his cardiology training at Harbor-UCLA Medical Center in Torrance, […]

Filed Under: Business/Financial News, Cardiac Implants, Cardiovascular, Implants, Structural Heart Tagged With: Impulse Dynamics, Personnel Moves

Impulse Dynamics completes $80m round

December 3, 2019 By Sean Whooley

Impulse Dynamics announced today that it completed a Series D financing round with new investors providing more than $80 million to the cardiac contractility modulation (CCM) therapy developer. The company said proceeds from the funding round totaling $80.25 million will be used to facilitate U.S. commercialization of its FDA-approved Optimizer Smart implantable device for CCM […]

Filed Under: Business/Financial News, Cardiovascular, Funding Roundup Tagged With: Impulse Dynamics

FDA approves Optimizer Smart heart failure device from Impulse Dynamics

March 21, 2019 By Brad Perriello

Updated to include commentary from Impulse Dynamics. The FDA today said it approved the Optimizer Smart heart failure device developed by Impulse Dynamics under its breakthrough device designation. The Stuttgart, Germany-based company’s device is designed to remodel the myocardium to increase the heart’s efficiency using “cardiac contractility modulation” – non-excitatory electrical pulses delivered to the […]

Filed Under: Cardiovascular, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Impulse Dynamics

FDA panel votes in support of Impulse Dynamic’s cardiac contractility modulation pulse generator

December 6, 2018 By Fink Densford

The FDA’s Circulatory Systems Device Panel this week voted in favor of Impulse Dynamics’s Optimizer Smart implantable pulse generator, supporting the company’s premarket approval application seeking clearance for use in patients suffering from heart failure, according to a Healio report. The Optimizer impulse generator is designed to remodel the myocardium to increase the heart’s efficiency […]

Filed Under: Cardiac Implants, Cardiovascular, Food & Drug Administration (FDA), Regulatory/Compliance, Structural Heart Tagged With: Impulse Dynamics

Impulse Dynamics wins FDA panel date for Optimizer PMA

October 29, 2018 By Fink Densford

Impulse Dynamics has set a date with the FDA’s Circulatory System Devices Panel, part of the agency’s Medical Device Advisory Committee, discussing the premarket application for the company’s Optimizer Smart impulse generator device. The Optimizer impulse generator is designed to remodel the myocardium to increase the heart’s efficiency using what the company calls the cardiac contractility […]

Filed Under: Cardiovascular, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: Impulse Dynamics

HRS 2018 Roundup: Device-related blood clots with Boston Scientific’s Watchman implant

May 11, 2018 By Brad Perriello

Data from a study of device-related blood clots and the Watchman cardiac implant made by Boston Scientific (NYSE:BSX), presented today at the annual meeting of the Heart Rhythm Society in Boston, indicate the need for aggressive management of patients at risk for device-related thrombosis. There were 74 incidences of DRT in 65 of the 1,739 Watchman […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8

Filed Under: Cardiovascular Tagged With: Apple, Bardy Diagnostics, Boston Scientific, Fitbit, HRS 2018, Impulse Dynamics, Imricor Medical Systems Inc., medicalgorithmics, Medtronic, Preventice, samsung

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy